Skip to content
KDGO 2026 Clinical Practice Guideline for Diabetes and Chronic Kidney Disease (CKD)
Chapter 1, Chapter 2, and Chapter 4 Update
CHAPTER 1: DEFINITIONS, PREVENTION, CASE-FINDING, STAGE AND CARDIOVACSULAR RISK
*
By agreeing to provide feedback on this draft guideline document, you hereby permit KDIGO to acknowledge your participation as a reviewer in the final publication.
**Please type your name as you wish for it to appear in the Guideline.**
(Required.)
First Name
Last Name
Affiliation
Email Address
1.1. Definitions
Practice Point 1.1.1. Use “diabetes and chronic kidney disease (CKD)”, “CKD in diabetes”, or “diabetic kidney disease” to identify people with type 1 diabetes (T1D) or type 2 diabetes (T2D) who have clinical evidence of CKD, with implications for treatment as evaluated in clinical trials enrolling similarly-defined populations.
Agree
Disagree
Chapter 1.1 Comments
4 / 14
29%
